tradingkey.logo

FDA Provides Early Alert On Defibrillation Lead Issue From Boston Scientific

ReutersAug 6, 2025 2:52 PM

- FDA:

  • FDA: PROVIDES EARLY ALERT ON DEFIBRILLATION LEAD ISSUE FROM BOSTON SCIENTIFIC

  • FDA: CERTAIN ENDOTAK RELIANCE DEFIBRILLATION LEADS WITH EXPANDED EPTFE COATED COILS MAY IMPACT SHOCK EFFICACY AND/OR REQUIRE EARLY REPLACEMENT

  • FDA: AS OF JULY 24, BOSTON SCIENTIFIC REPORTED 386 SERIOUS INJURIES, 16 PATIENT DEATHS ASSOCIATED WITH DEFIBRILLATION LEAD ISSUE- WEBSITE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI